[arista]

[A new twice-yearly asthma injection,
Depomycin (brand name Exdensur),
has been approved by the UK and US regulators
for severe asthma,
But its initial availability will likely be
through private healthcare
with a high price tag.

The cost has led to concerns about accessibility,
at least in the short term]


Was on SkyNews Newspaper Review 8:45 AM


Twice a Year will help.

[Livia]

Only the rich deserve to live healthy. Well done NHS.